Glaxosmithkline | GSK - Trade Creditors


Glaxosmithkline reported GBP20.72B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Bausch Health Companies USD 593M 7M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Canopy Growth CAD 19.96M 1.83M Dec/2025
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
J&J USD 10.46B 1.53B Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Takeda JPY 491.34B 23.75B Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Zoetis USD 507M 20M Mar/2026